Patents Assigned to Gense S.A.
  • Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity
    Publication number: 20070054845
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GZIP polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: October 3, 2002
    Publication date: March 8, 2007
    Applicant: Gense S.A.
    Inventors: Ilya Chumakov, Oxana Guerassimenko